ClinicalTrials.Veeva

Menu

Ultrasonography SWE for Hepatic Fibrosis Evaluation

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Cirrhosis

Treatments

Device: ultrasound shear wave elastography

Study type

Observational

Funder types

Other

Identifiers

NCT02673411
SNUH-2016-0065

Details and patient eligibility

About

The purpose of this study is to measure diagnostic performance of ultrasound shear wave elastography to detect advanced hepatic fibrosis.

Full description

Hepatic fibrosis causes liver dysfunction and HCC. Since hepatic fibrosis is reversible dynamic condition, its monitoring is important to predict long term outcome and to determine treatment plan.

The reference of standard to diagnose hepatic fibrosis is biopsy, but recently non-invasive method such as stiffness imaging has been drawing a lot of attention. In this study, ultrasound shear wave elastography will be performed and its diagnostic performance to detect advanced hepatic fibrosis (= > F2) will be measured using histologic grade as a reference.

Enrollment

140 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • volunteers who agree to undergo US shear elastography OR
  • patients with chronic liver disease who are scheduled to undergo liver resection or liver parenchymal biopsy.

AND

  • = or > 18 years
  • sign informed consent

Exclusion criteria

  • none

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems